Optimal size and location for corneal rotational autografts: a simplified mathematical model

Archives of Ophthalmology
Natalie A AfshariDimitri T Azar

Abstract

To calculate clinical guidelines for the optimal location and size of a rotational autokeratoplasty. The ideal graft size and trephine decentration for a rotational autograft were calculated based on scar location using geometric models. Mathematical variables were set to maximize postoperative visual acuity and for generalization of the geometric model. This model was used in a rotational autokeratoplasty of a patient with a history of a corneal scar and diplopia. An 8-mm autograft was decentered 0.5 mm superiorly and rotated 180 degrees to relocate the scar to the superior aspect of the cornea, out of the patient's vision. For cases that satisfy the given variables, a graft diameter of 8 mm with a decentration of 0.5 mm balances maximization of scar removal and scar movement superiorly, with minimization of discrepancy in corneal thickness after rotation. For scars that are alpha degrees from horizontal, the graft should be rotated 180 - alpha degrees . By using these calculations, the autograft in this case successfully resolved the diplopia and improved visual acuity. A rotational autograft can be an effective alternative to standard penetrating keratoplasty for some patients with corneal scars. We establish a mathematical ...Continue Reading

Citations

Oct 26, 2012·Case Reports in Ophthalmological Medicine·Alime GünesHüseyin Bayramlar
Jan 13, 2009·Eye·F Arnalich-Montiel, J K G Dart
Jul 16, 2008·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A A BialasiewiczG R Syed
Jan 5, 2018·Cornea·Myriam CassagnePierre Fournié
Jun 19, 2010·Current Opinion in Ophthalmology·Vishal JhanjiRasik B Vajpayee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.